Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adamas nets $42.7mm via IPO

Executive Summary

Adamas Pharmaceuticals Inc. (working on combination therapies for central nervous system disorders) netted $42.7mm in its initial public offering of 3.08mm common shares (including the overallotment) at $16 each, the low end of its intended $16-18 range.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies